Lyphe Dispensary Broadens Noidecs Vital Collection – High-Quality, Affordable Medical Cannabis.  

Lyphe Dispensary is delighted to announce the expansion of the Noidecs Vital collection – an affordable, high-quality range of medical cannabis products developed in direct response to patient feedback.  

Building on the success of Noidecs Vital Platinum OG, launched in June 2024, the Noidecs Vital range includes four new distinct SKUs aimed at making the medical cannabis purchase journey more straight forward for patients.

The Noidecs Vital product line features a carefully curated selection of full flower medical cannabis options: Vital One, Vital Two, Vital Three, and Vital Four. Vital One contains the lowest THC level, making it ideal for patients seeking gentle relief or those new to cannabis. As the THC concentration increases with each subsequent product, Vital Four offers the highest level of THC, catering to patients who are suffering from chronic conditions such as severe pain, while remaining at a stable, affordable price.

This tiered approach ensures that patients can easily identify and select the formulation that best aligns with their individual therapeutic needs and preferences. 

Patients are advocating for lower cost, yet sustainable options, and we want them to know that Lyphe is not only listening but taking action.”

Comments Hayley Thompson, Managing Director at Lyphe Clinic.

The Noidecs Vital line aims to bridge the gap between quality and cost, offering patients a reliable and accessible option for managing their health conditions. 

The expanded range highlights Lyphe’s commitment to delivering cost conscious medical cannabis without compromising on quality or freshness. Patients benefit from lower prices, made possible by economies of scale and an expedited supply chain focused on quality and THC content.  

Noidecs Vital launches in Winter 2024 and will be available for purchase by qualifying patients on.   

For more details on Lyphe Clinc or to learn more about Lyphe’s product CBD line, click here 

For media inquiries, contact Becky McLaren, Marketing Manager, at: becky.mclaren@lyphe.com 

Disclaimer

The content provided on this blog is intended for educational purposes only and should not be construed as medical advice. We strongly advise readers to seek guidance from a qualified healthcare professional regarding any medical concerns.
To reflect its medicinal nature rather than recreational use, we prefer the term ‘medical cannabis’ over terms such as ‘marijuana’, “grass”. or ‘dope’ which may carry negative connotations.
The opinions expressed in the blog belong to the respective authors, who are not medical professionals, and may not necessarily align with those of Lyphe Clinic. Lyphe Clinic does not endorse any specific products or services mentioned, except those provided through Lyphe Clinic.
Readers should be aware that the legality of medical cannabis varies by location, and this disclaimer may be subject to periodic updates.

Related Insights

Whilst you’re here you might also like to read…